JP2007512366A5 - - Google Patents

Download PDF

Info

Publication number
JP2007512366A5
JP2007512366A5 JP2006541621A JP2006541621A JP2007512366A5 JP 2007512366 A5 JP2007512366 A5 JP 2007512366A5 JP 2006541621 A JP2006541621 A JP 2006541621A JP 2006541621 A JP2006541621 A JP 2006541621A JP 2007512366 A5 JP2007512366 A5 JP 2007512366A5
Authority
JP
Japan
Prior art keywords
pravastatin
compactin
amount
composition
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006541621A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007512366A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/039217 external-priority patent/WO2005051372A2/en
Publication of JP2007512366A publication Critical patent/JP2007512366A/ja
Publication of JP2007512366A5 publication Critical patent/JP2007512366A5/ja
Pending legal-status Critical Current

Links

JP2006541621A 2003-11-24 2004-11-23 プラバスタチンの精製方法 Pending JP2007512366A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US52549403P 2003-11-24 2003-11-24
US53231403P 2003-12-22 2003-12-22
US55416504P 2004-03-18 2004-03-18
PCT/US2004/039217 WO2005051372A2 (en) 2003-11-24 2004-11-23 Method of purifying pravastatin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009024212A Division JP2009161542A (ja) 2003-11-24 2009-02-04 プラバスタチンの精製方法

Publications (2)

Publication Number Publication Date
JP2007512366A JP2007512366A (ja) 2007-05-17
JP2007512366A5 true JP2007512366A5 (cg-RX-API-DMAC7.html) 2008-11-20

Family

ID=34637188

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006541621A Pending JP2007512366A (ja) 2003-11-24 2004-11-23 プラバスタチンの精製方法
JP2009024212A Pending JP2009161542A (ja) 2003-11-24 2009-02-04 プラバスタチンの精製方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009024212A Pending JP2009161542A (ja) 2003-11-24 2009-02-04 プラバスタチンの精製方法

Country Status (12)

Country Link
US (2) US7425644B2 (cg-RX-API-DMAC7.html)
EP (2) EP2033636A1 (cg-RX-API-DMAC7.html)
JP (2) JP2007512366A (cg-RX-API-DMAC7.html)
AT (1) ATE412409T1 (cg-RX-API-DMAC7.html)
CA (1) CA2546377A1 (cg-RX-API-DMAC7.html)
DE (3) DE202004020671U1 (cg-RX-API-DMAC7.html)
ES (1) ES2251894T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20080686T3 (cg-RX-API-DMAC7.html)
PL (1) PL1641447T3 (cg-RX-API-DMAC7.html)
PT (1) PT1641447E (cg-RX-API-DMAC7.html)
TW (1) TWI319707B (cg-RX-API-DMAC7.html)
WO (1) WO2005051372A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005121062A2 (en) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Process for the preparation of pravastatin
JP4775727B1 (ja) * 2010-08-17 2011-09-21 貞宏 平山 印刷物の微小マークによる一般人が容易にできる真贋判定方法
WO2014119568A1 (ja) * 2013-01-29 2014-08-07 学校法人産業医科大学 シスプラチン耐性がんの治療のためのHMG-CoA還元酵素阻害薬の使用

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4319039A (en) * 1979-06-15 1982-03-09 Merck & Co., Inc. Preparation of ammonium salt of hypocholesteremic fermentation product
US4346277A (en) * 1979-10-29 1982-08-24 Eaton Corporation Packaged electrical heating element
MX7065E (es) 1980-06-06 1987-04-10 Sankyo Co Un procedimiento microbiologico para preparar derivados de ml-236b
ATE69602T1 (de) * 1985-09-13 1991-12-15 Sankyo Co Hydroxy-ml-236b-derivate, deren herstellung und anwendung.
US4857547A (en) * 1988-01-07 1989-08-15 Merck & Co., Inc. Novel HMG-CoA reductase inhibitors
US4857522A (en) 1988-03-21 1989-08-15 E. R. Squibb & Sons, Inc. Derivatives of pravastatin for inhibiting cholesterol biosynthesis
US5180589A (en) * 1988-03-31 1993-01-19 E. R. Squibb & Sons, Inc. Pravastatin pharmaceuatical compositions having good stability
US5099035A (en) * 1989-02-27 1992-03-24 E. R. Squibb & Sons, Inc. Mevinic acid derivatives useful as antihypercholesterolemic agents and method for preparing same
US5140012A (en) * 1990-05-31 1992-08-18 E. R. Squibb & Sons, Inc. Method for preventing onset of restenosis after angioplasty employing pravastatin
US5202029A (en) 1991-03-13 1993-04-13 Caron Kabushiki Kaisha Process for purification of hmg-coa reductase inhibitors
US5157025A (en) * 1991-04-01 1992-10-20 E. R. Squibb & Sons, Inc. Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
UA45304C2 (uk) 1992-05-20 2002-04-15 Басф Аг Похідні пептиду або їх солі, фармацевтична композиція
NZ250609A (en) * 1992-12-28 1995-07-26 Sankyo Co Hexahydronaphthalene esters and ring closed lactones; preparation and medicaments
SI9300303A (en) * 1993-06-08 1994-12-31 Krka Tovarna Zdravil Process for isolation of hypolipemic effective substance
IL112639A0 (en) 1994-03-11 1995-05-26 Bristol Myers Squibb Co A pharmaceutical composition containing pravastin
US5942423A (en) 1995-06-07 1999-08-24 Massachusetts Institute Of Technology Conversion of compactin to pravastatin by actinomadura
US5616595A (en) * 1995-06-07 1997-04-01 Abbott Laboratories Process for recovering water insoluble compounds from a fermentation broth
WO1997006128A1 (en) 1995-08-03 1997-02-20 Gist-Brocades B.V. Selective process for the deacylation of acylated compounds
US5883109A (en) 1996-07-24 1999-03-16 Bristol-Myers Squibb Company Method for lowering serum lipid levels employing an MTP inhibitor in combination with another cholesterol lowering drug
AU6726398A (en) 1997-02-20 1998-09-09 Gist-Brocades B.V. Nitrogen feed in statin fermentation
KR100210482B1 (ko) 1997-04-10 1999-07-15 김종인 스트렙토마이세스엑스포리아투스(streptomycesexfoliatus)yj-118과이를이용한프라바스타틴나트륨의제조방법
AU9264598A (en) 1997-08-22 1999-03-16 Gist-Brocades B.V. Statin production by fermentation
SI9800046A (sl) 1998-02-18 1999-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti
JP2931971B1 (ja) 1998-02-23 1999-08-09 利夫 佐藤 プラバスタチンの製造法
SI20072A (sl) * 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze
SI20305A (sl) 1999-08-06 2001-02-28 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Kristali natrijeve soli pravastatina
SK10932001A3 (sk) 1999-02-03 2002-06-04 Institute For Drug Research Ltd. Mikrobiálny spôsob výroby pravastatínu
US6682913B1 (en) 1999-02-03 2004-01-27 Institute For Drug Research Ltd. Microbial process for preparing pravastatin
HUP9902352A1 (hu) 1999-07-12 2000-09-28 Gyógyszerkutató Intézet Kft. Eljárás pravasztatin mikrobiológiai előállítására
WO2001039768A1 (en) * 1999-11-30 2001-06-07 Biogal Gyogyszergyar Rt Process for recovering statin compounds from a fermentation broth
WO2001081611A1 (en) * 2000-04-27 2001-11-01 Biocon India Limited A novel process for the manufacture and purification of compactin
HRP20030347A2 (en) * 2000-10-05 2005-04-30 Teva Gy�gyszergy�r R�szv�nyt�rsas�g Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same
JP3463881B2 (ja) * 2002-08-06 2003-11-05 三共株式会社 プラバスタチン又はその薬理上許容される塩の単離・精製方法
TW589178B (en) * 2003-02-21 2004-06-01 China Chemical & Pharmaceutica A novel industrial process to obtain pravastatin sodium of high purity

Similar Documents

Publication Publication Date Title
JPH0249797A (ja) エリスロマイシンaオキシム及びその塩の製造方法
JPH11505229A (ja) 4−アリール−ピペリジン誘導体を製造する方法
CN105294496A (zh) 一种西酞普兰中间体的制备方法
JP2011144159A5 (cg-RX-API-DMAC7.html)
CN114805206B (zh) 高光学纯度瑞美吉泮中间体的工业化制备方法
JP2018532718A (ja) ホスホルアミダート化合物及びその製造方法並びに結晶
KR20100022081A (ko) 결정성 로티고틴 염기 및 이의 제조 방법
JP2843592B2 (ja) L−リボース誘導体
JP5664870B2 (ja) 3環性ベンゾピラン化合物の新規な結晶形態及びその製造方法
JP2006528203A (ja) レバルブテロールヒドロクロリド多形a
KR101946808B1 (ko) 결정성 3',5'-사이클릭 디구아닐산
EP1446397A1 (en) Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives
WO2001036359A1 (en) Optically active fluorinated binaphthol derivative
CN109705096B (zh) 一种盐酸法舒地尔的精制方法
KR102958083B1 (ko) 고체 형태의 tert-부틸 (S)-2-((2S,3R)-1-아미노-3-히드록시-1-옥소부탄-2-일)-1-옥소-2,5-디아자스피로[3.4]옥탄-5-카르복실레이트 및 제조 방법
JP2006506420A (ja) 老化及びストレス調節用の薬学的に有用な新規ダウワーフェロモン化合物及びその分離精製方法
CN101805339A (zh) 一种新方法的恩替卡韦化合物
JP2003523991A (ja) (2s)−アミノインダン誘導体、その製法および選択的ドーパミンd3リガンドとしてのその使用
EP2367831A1 (en) A method for the manufacture of highly pure prasugrel
CN118878449B (zh) DC-Rhoin类似物及其制备方法和应用
ES2251894T1 (es) Procedimiento para la purificacion de pravastatina.
JP2007230902A (ja) L−グルロン酸金属塩又はd−マンヌロン酸金属塩の製造方法
KR20220066118A (ko) B형 간염 표면 항원 억제제의 결정형 및 이의 용도
TW202423418A (zh) 雙環類化合物的無定形、結晶固體及其製備方法
JPH0432828B2 (cg-RX-API-DMAC7.html)